Subscribe

Main navigation

Home
Conferences
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Support

Search results

Questioning America’s Approach to Transgender Health Care

September 20, 2022
Spotlight
When Jane Clark’s 15-year-old daughter told her that she thought she might be gay, Dr Clark, a paediatrician who calls herself a “typical west-coast liberal”, said, “ok, great.” When the child a few months later said she thought she was non-binary, “I was, like, I don’t know what that means, but ok...
Matched fragments:
… and medical transition, including puberty blockers, cross-sex hormones and … that studies on the impact of puberty blockers are “either of …

Clinical and Ethical Considerations in the Treatment of Gender Dysphoric Children and Adolescents: When Doing Less Is Helping More

November 22, 2021
Studies

Consistent with the principle, “First, do no harm,” psychologist David Schwartz, Ph.D. exhorts clinicians to treat children and adolescents with gender dysphoria (GD) using psychotherapy rather than pharmacological and surgical interventions. He asserts, “in the treatment of children and...

Matched fragments:
… genetic make-up of the child, or puberty blockers, are all clinical practices … we are instigating.” Although puberty blockers are promoted as “a …

Bone Mass in Young Adulthood Following Gonadotropin-Releasing Hormone Analog Treatment and Cross-Sex Hormone Treatment in Adolescents With Gender Dysphoria

February 1, 2015
Studies

SEGM Summary:

This retrospective study looked at bone mineral density (BMD) in 34 young gender dysphoric adults at the average age of 22, who had been given gonadotropin releasing hormone analog (GnRHa) to suppress or delay puberty for 1.3 - 1.5 years, followed by cross-sex hormones for...

Matched fragments:
… (DSM IV-TR) who started SR in puberty and had undergone … (GnRHa) to suppress or delay puberty for 1.3 - 1.5 years, … young adults treated with puberty blockers during mid-adolescence had …

Evidence review: gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria

January 1, 2020
Studies

In 2020, the UK National Institute for Health and Care Excellence (NICE) undertook two systematic evidence reviews of the use of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as treatments for...

Matched fragments:
… of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as …

A big transgender-rights case heads to America’s Supreme Court

December 22, 2024
Spotlight
The following publication appeared in the Economist online on December 2, 2024. The article has been reproduced below fully, with permission.
Matched fragments:
… Senate Bill 1 (SB1), which bans puberty blockers, cross-sex hormones and … identify as transgender and want puberty blockers or hormones (the …

National Academy of Medicine in France Advises Caution in Pediatric Gender Transition

March 3, 2022
Spotlight
The National Academy of Medicine in France has issued a press release in which it cautions medical practitioners that the growing cases of transgender identity in young people are often socially-mediated and that great caution in treatment is needed. The Academy draws attention to...
Matched fragments:
… Stockholm to prohibit the use of puberty blockers. If France allows the use of puberty blockers or cross-sex …

Care of children and adolescents with gender dysphoria: summary

December 1, 2022
Studies
Background

In February 2022, the Swedish National Board of Health and Welfare (NBHW) issued an update to its health care service guidelines...

False Assumptions Behind Youth Gender Transitions

December 30, 2022
Spotlight
A recent publication examines and refutes several key assumptions that underlie an influential “pro-affirmation” paper published by the journal Nature.
Matched fragments:
… gender dysphoria during or after puberty, challenge the notion that a … The Endocrine Society’s protocol (puberty blockers at the earliest stage of …

Pediatric gender affirming care is not evidence-based

May 10, 2025
Studies

Over the last two years there has been a surge in research studies and systematic reviews reporting on the use of puberty blockers and cross-sex hormones as treatment for gender-distressed youth. This makes it difficult for the non-specialist to keep on top of the evidence. The psychiatrist...

Matched fragments:
… for risks and benefits of puberty blockers and gender-affirming … reviews reporting on the use of puberty blockers and cross-sex hormones as …

Informed Consent for Gender-Affirmative Care

March 22, 2022
Spotlight
Trans-identified youth present to clinicians as strongly desiring hormones and surgery. However, this conviction should not be confused with the capacity to carefully consider the consequences of gender transition, argues a recent article about informed consent in gender medicine,...
Matched fragments:
… which entails the use of puberty blockers, cross-sex hormones, and … problems of youth with post-puberty onset of gender …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • …
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM